155 related articles for article (PubMed ID: 26032129)
41. Discriminatory power of MRI for differentiation of adrenal non-adenomas vs adenomas evaluated by means of ROC analysis: can biopsy be obviated?
Slapa RZ; Jakubowski W; Januszewicz A; Kasperlik-Zaluska AA; Dabrowska E; Fijuth J; Feltynowski T; Tarnawski R; Królicki L
Eur Radiol; 2000; 10(1):95-104. PubMed ID: 10663723
[TBL] [Abstract][Full Text] [Related]
42. Radiologic evaluation of incidentally discovered adrenal masses.
Willatt JM; Francis IR
Am Fam Physician; 2010 Jun; 81(11):1361-6. PubMed ID: 20521756
[TBL] [Abstract][Full Text] [Related]
43. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
[TBL] [Abstract][Full Text] [Related]
44. Chemical-shift MRI versus washout CT for characterizing adrenal incidentalomas.
Warda MH; Shehata SM; Zaiton F
Clin Imaging; 2016; 40(4):780-7. PubMed ID: 27317224
[TBL] [Abstract][Full Text] [Related]
45. Adrenal incidentalomas--analysis of 23 cases discovered by ultrasound.
Goncalvesová E; Hnilica P; Motovská Z; Goncalves F; Kovác A
Neoplasma; 1997; 44(2):137-41. PubMed ID: 9201295
[TBL] [Abstract][Full Text] [Related]
46. CT time-attenuation washout curves of adrenal adenomas and nonadenomas.
Korobkin M; Brodeur FJ; Francis IR; Quint LE; Dunnick NR; Londy F
AJR Am J Roentgenol; 1998 Mar; 170(3):747-52. PubMed ID: 9490968
[TBL] [Abstract][Full Text] [Related]
47. Differences in Growth Rate on CT of Adrenal Adenomas and Malignant Adrenal Nodules.
Corwin MT; Navarro SM; Malik DG; Loehfelm TW; Fananapazir G; Wilson M; Campbell MJ
AJR Am J Roentgenol; 2019 Sep; 213(3):632-636. PubMed ID: 31039016
[No Abstract] [Full Text] [Related]
48. [The role of echography in the diagnosis of adrenal masses].
Martino P
Arch Ital Urol Androl; 1993 Aug; 65(4):337-40. PubMed ID: 8353537
[TBL] [Abstract][Full Text] [Related]
49. Evaluate the efficacy of minimum attenuation value in differentiation of adrenal adenomas from nonadenomas on unenhanced CT.
Zhu M; Qu J; Han Z
Clin Imaging; 2016; 40(1):86-9. PubMed ID: 26439657
[TBL] [Abstract][Full Text] [Related]
50. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
[TBL] [Abstract][Full Text] [Related]
51. Adrenal tissue characterization using MR imaging.
Glazer GM; Woolsey EJ; Borrello J; Francis IR; Aisen AM; Bookstein F; Amendola MA; Gross MD; Bree RL; Martel W
Radiology; 1986 Jan; 158(1):73-9. PubMed ID: 3940402
[TBL] [Abstract][Full Text] [Related]
52. Contrast-enhanced ultrasonographic characteristics of adrenal glands in dogs with pituitary-dependent hyperadrenocorticism.
Bargellini P; Orlandi R; Paloni C; Rubini G; Fonti P; Peterson ME; Boiti C
Vet Radiol Ultrasound; 2013; 54(3):283-92. PubMed ID: 23441645
[TBL] [Abstract][Full Text] [Related]
53. Enhancement patterns of adrenal nodules on magnetic resonance imaging.
Yamauchi FI; Lemos GR; Dubinco A; Paiva OA; Mussi TC; Baroni RH
Int Braz J Urol; 2022; 48(2):294-302. PubMed ID: 35170891
[TBL] [Abstract][Full Text] [Related]
54. Virtual Noncontrast Images From Portal Venous Phase Spectral-Detector CT Acquisitions for Adrenal Lesion Characterization.
Laukamp KR; Kessner R; Halliburton S; Zopfs D; Gupta A; Große Hokamp N
J Comput Assist Tomogr; 2021 Jan-Feb 01; 45(1):24-28. PubMed ID: 32168080
[TBL] [Abstract][Full Text] [Related]
55. [Imaging methods in diagnosis of pheochromocytoma].
Neumann K; Langer R
Zentralbl Chir; 1997; 122(6):438-42. PubMed ID: 9334109
[TBL] [Abstract][Full Text] [Related]
56. Update on CT and MRI of Adrenal Nodules.
Schieda N; Siegelman ES
AJR Am J Roentgenol; 2017 Jun; 208(6):1206-1217. PubMed ID: 28225653
[TBL] [Abstract][Full Text] [Related]
57. The indeterminate adrenal lesion.
Sahdev A; Willatt J; Francis IR; Reznek RH
Cancer Imaging; 2010 Mar; 10(1):102-13. PubMed ID: 20299300
[TBL] [Abstract][Full Text] [Related]
58. Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls.
Johnson PT; Horton KM; Fishman EK
Radiographics; 2009; 29(5):1333-51. PubMed ID: 19755599
[TBL] [Abstract][Full Text] [Related]
59. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
[TBL] [Abstract][Full Text] [Related]
60. The role of CnTI-SonoVue in the diagnosis of ovarian masses with papillary projections: a preliminary study.
Testa AC; Timmerman D; Exacoustos C; Fruscella E; Van Holsbeke C; Bokor D; Arduini D; Scambia G; Ferrandina G
Ultrasound Obstet Gynecol; 2007 May; 29(5):512-6. PubMed ID: 17444549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
